BREAKING NEWS

US Supreme Court justices divided over Teva MS patent battle

By REUTERS

OCTOBER 15, 2014 18:20

WASHINGTON - The US Supreme Court on Wednesday appeared closely divided as it weighed Teva Pharmaceutical Industries Ltd's high-profile fight with generic drug manufacturers over patent protections for Copaxone, its top-selling multiple sclerosis drug.

Israel-based Teva is battling to protect a key patent for the drug that is due to expire in September 2015. It is one of the most important business cases of the current term for the nine Supreme Court justices.

There are two teams developing cheaper generic forms of Copaxone: one involving Novartis AG's Sandoz Inc and Momenta Pharmaceuticals Inc and another involving Mylan Inc and Natco Pharma Ltd.

IDF attacks Hezbollah targets, sirens sound in Metula

By JERUSALEM POST STAFF

04/23/2024 08:59 AM

Russia says it has a response ready if West seizes its assets - RIA

By REUTERS

04/23/2024 08:46 AM

Israeli police ask for assistance locating missing teenager

By MAARIV

04/23/2024 07:15 AM

US to take aim at Chinese banks aiding Russia war effort, WSJ reports

By REUTERS

04/23/2024 06:15 AM